Join ASGCT and save up to $350 on Annual Meeting registration!
Learn more about sessions and presentations at the 26th Annual Meeting
Wednesday, May 17 2023 08:00 AM – 09:45 AM PT
The proposed session will focus on how novel uses of technologies such as digital biomarkers, optogenetics, imaging, etc., have broad potential to: (1) advance biological and clinical understanding of neurodevelopmental, neurodegenerative and neuropsychiatric disorders (2) lead to novel therapeutic approaches and (3) accelerate translational and clinical development of cell and gene therapies for a range of neurological disorders.
08:00 AM – 09:45 AM - Room 408 AB
Abla A. Creasey. CIRM, West Sacramento, CA
Shyam Patel. , CA
08:01 AM – 08:10 AM - Room 408 AB
Abla A.. Creasey. CIRM, West Sacramento, CA
Shyam Patel. California Institute for Regenerative Medicine, CA
08:10 AM – 08:40 AM - Room 408 AB
Krystof Bankiewicz, MD, PhD. The Ohio State University, Columbus, OH, University of California San F...
09:00 AM – 09:45 AM - Room 408 AB
Claire Henchcliffe, MD DPhil. University of California, Irvine, Irvine, CA
Hartmuth Kolb. , CA
© 2000-2023 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico